-
Supplementing Single-Arm Trial Data in NICE Submissions: Are Synthetic Approaches Leading the Charge?
Sep 9, 2025, 16:22 PM -
Assessing the Impact of Technology-Powered, Pharmacy- and Nursing-Supported Direct Oral Anticoagulant Management
Sep 9, 2025, 16:22 PM -
Network Meta-Analysis NMA of Clinical Effectiveness of Second-Line (2L+) Treatments in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Sep 9, 2025, 16:22 PM -
From GVD to HTA: Preparing for Success in the EU JCA Era With GenAI-Enhanced Efficiency
Sep 9, 2025, 16:22 PM -
The Cost-Effectiveness of a Novel Scalp Cooling Device to Alleviate Chemotherapy-Induced Alopecia in Patients With Early Breast Cancer
Sep 9, 2025, 16:22 PM -
AI Time and Motion - Analysis of the Accuracy and Efficiency of AI for HTA-Standard SLRs
Sep 9, 2025, 16:22 PM -
Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Benefits of Obesity Prevalence Reduction in China: A Public Economic Perspective
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Nivolumab Plus Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable NSCLC in Greece
Sep 9, 2025, 16:22 PM -
The Safety and Effectiveness of Drug-Induced Sleep Endoscopy in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Dimethyl Fumarate for the Treatment of Relapsing/Remitting Multiple Sclerosis in Iraq
Sep 9, 2025, 16:22 PM -
How Cost-Effectiveness and Budget Impact Drive Pricing and Reimbursement: Insights From an International Comparative Study
Sep 9, 2025, 16:22 PM -
Clinical Effectiveness and Safety of Second-Line Therapies for Immune Thrombocytopenia (ITP): A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)
Sep 9, 2025, 16:22 PM -
The Use of Multiple Sleep Medications Is Highly Prevalent
Sep 9, 2025, 16:22 PM -
Pegunigalsidase Alfa Elfabrio® as a Long-Term Enzyme Replacement Therapy in Adults With Fabry Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Isavuconazole vs. Liposomal Amphotericin B for the Treatment of Invasive Mucormycosis in Morocco
Sep 9, 2025, 16:22 PM -
Guidance for Real-World Evidence Generation for the Joint Clinical Assessment Process and Its Implications for Country-Specific HTA Body Acceptability
Sep 9, 2025, 16:22 PM -
Impact of Proteinuria and Declining Kidney Function on the Healthcare Resource Utilization and Associated Costs of Patients With IgA Nephropathy: A Retrospective Analysis in the UK and Spain
Sep 9, 2025, 16:22 PM -
Organizational and Environmental Impact of Switching From Intravenous to Subcutaneous Immune Checkpoint Inhibitors (ICIs) in France: A Real-World Analysis Using PMSI Data
Sep 9, 2025, 16:22 PM
